Last Updated: 03-07-2026
Welcome to the website of Vilin Bio Med Limited (“Vilin Bio,” “Company,” “we,” “us,” or “our”), accessible at www.vilinbio.com (“Website”). These Terms & Conditions (“Terms”) govern your access to and use of the Website. By accessing or using this Website, you agree to be bound by these Terms. If you do not agree, please discontinue use of the Website.
1. About Us
Vilin Bio Med Limited is a pharmaceutical and healthcare group listed on the National Stock Exchange (NSE), operating through its group entities including Vilin Bio Med Inc. (USA), Vilin Oncology, and Vilin Bio Med (Jamaica), and its specialized brand divisions Skinvil, Good Choice, and Oravil.
2. Use of Website
You agree to use this Website only for lawful purposes and in a manner that does not infringe the rights of, or restrict or inhibit the use of, this Website by any third party. Prohibited uses include, but are not limited to:
- Attempting unauthorized access to any part of the Website or its systems
- Uploading or transmitting viruses, malware, or harmful code
- Using automated systems (bots, scrapers) to extract data without permission
- Impersonating any person or entity, or misrepresenting your affiliation
- Using the Website to transmit unsolicited or unauthorized advertising
3. Intellectual Property
All content on this Website — including text, graphics, logos, images, corporate data, investor materials, and the overall design — is the property of Vilin Bio Med Limited or its licensors and is protected by applicable intellectual property laws. You may not reproduce, distribute, modify, or create derivative works from any content on this Website without our prior written consent, except for personal, non-commercial use.
4. Investor Relations Content
Information published in the Investor Relations section (including financial data, disclosures, and downloadable documents) is provided for general informational purposes only and:
- Does not constitute investment advice, an offer, or a solicitation to buy or sell securities
- May not reflect the most current corporate developments; users should refer to official filings with NSE/SEBI for authoritative information
- Is subject to change without prior notice
Vilin Bio Med Limited complies with applicable SEBI (Listing Obligations and Disclosure Requirements) Regulations for all official disclosures. In case of any discrepancy between information on this Website and official regulatory filings, the regulatory filings shall prevail.
5. No Professional or Medical Advice
Content related to our pharmaceutical products, drug molecules, or healthcare brand divisions (Skinvil, Good Choice, Oravil) is provided for general informational purposes only and does not constitute medical, clinical, or professional advice. Always consult a qualified healthcare professional before making decisions related to medical treatment or product use.
6. Third-Party Links
This Website may contain links to third-party websites, including our brand division websites (skinvil.com, goodchoice.health, oravil.health) and other external resources. These links are provided for convenience only. We do not endorse and are not responsible for the content, accuracy, or practices of any linked third-party website.
7. Careers and Job Applications
Submission of a resume, CV, or job application through this Website does not guarantee an interview, offer, or employment. All applications are reviewed at the sole discretion of Vilin Bio Med Limited’s hiring team.
8. WhatsApp and Communication Channels
Where available, communication via WhatsApp or other messaging channels on this Website is provided as a convenience for general inquiries. Response times are not guaranteed, and these channels should not be used for urgent, medical, or time-sensitive matters.
9. Disclaimer of Warranties
This Website and its content are provided on an “as is” and “as available” basis without warranties of any kind, whether express or implied, including but not limited to warranties of accuracy, completeness, merchantability, fitness for a particular purpose, or non-infringement. We do not warrant that the Website will be uninterrupted, error-free, or free of viruses or harmful components.
10. Limitation of Liability
To the fullest extent permitted by applicable law, Vilin Bio Med Limited, its group entities, directors, officers, and employees shall not be liable for any direct, indirect, incidental, consequential, or punitive damages arising out of or related to your use of, or inability to use, this Website, even if advised of the possibility of such damages.
11. Indemnification
You agree to indemnify and hold harmless Vilin Bio Med Limited and its group entities from any claims, losses, liabilities, damages, and expenses (including legal fees) arising from your violation of these Terms or misuse of the Website.
12. Governing Law and Jurisdiction
These Terms shall be governed by and construed in accordance with the laws of India. Any disputes arising out of or in connection with these Terms shall be subject to the exclusive jurisdiction of the courts located in [insert city, e.g., Mumbai/New Delhi], India.
13. Changes to These Terms
We reserve the right to modify or update these Terms at any time without prior notice. Continued use of the Website after changes are posted constitutes your acceptance of the revised Terms. The “Last Updated” date above reflects the most recent revision.
14. Severability
If any provision of these Terms is found to be invalid or unenforceable, the remaining provisions shall continue in full force and effect.
15. Contact Us
For questions regarding these Terms & Conditions, please contact:
Vilin Bio Med Limited Email: Investor Relations: investor@vilinbio.com Business Development: bd@vilinbio.com Registered Office: Plot No.43, Rd Number 2, Sagar Society, Banjara Hills, Hyderabad, Telangana 500034
Note: This document is a template drafted for website implementation purposes. As an NSE-listed pharmaceutical company, please have this reviewed by qualified legal counsel to ensure full compliance with SEBI/NSE regulations, the Companies Act, applicable pharmaceutical advertising laws, and jurisdiction-specific requirements for the USA and Jamaica entities before publishing.